Dutch-based Reyedar raises €3M for early detection of neurodegenerative diseases siliconcanals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siliconcanals.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and.
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases, progressive familial intrahepatic cholestasis and Alagille syndrome Data to be. | June 12, 2023
New research has identified over 300 molecules differentially abundant in the faeces of IBD patients, independent of confounders, which researchers say paves the way for future interventions targeting intestinal inflammation.
Early, rapid, and sustained efficacy across wide range of patients with evidence of disease modificationLong-term preservation of native liver in PFIC, improvements in pruritus, bile acids, and. | November 7, 2022